Short description
Celladon is a biotechnology company developing molecular therapies for the treatment of heart failure.
Description
Celladon Corporation, a biotechnology company, develops and manufactures molecular therapies for the treatment of heart failure. Its products include SERCA2a, an enzyme that regulates calcium cycling and contractility in heart muscle cells; and MYDICAR, an enzyme replacement therapy for heart failure. Celladon was founded in 2000 and is based in La Jolla, California.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
La Jolla, California, United States, North America
Founded on
January 1, 2000
Exited on
January 31, 2014
Went public on
January 31, 2014
Delisted on
March 22, 2016
Stock symbol
CLDN
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noway Youcantaccess, Noaccess, Uh Ohhhh, Cannot Access, Cannot Access, Noway Youcantaccess, Absolutely Noaccess, Noway Youcantaccess, No Way, Noaccess, Cannot Access, Uh Ohhhh, Noaccess, Noaccess, Cannot Access, Uh Ohhhh, Noaccess
Sign in for full access
Founders
Roger Hajjar